首页|期刊导航|中国感染控制杂志|19株多杀巴斯德菌感染的临床特征和病原学特点

19株多杀巴斯德菌感染的临床特征和病原学特点OA

Clinical and pathogenic characteristics of infection of 19 Pasteurella multocida strains

中文摘要英文摘要

目的 分析临床分离的多杀巴斯德菌临床特征、药敏结果及分子分型特征,为临床诊治提供依据.方法 回顾性收集2020年12月—2024年12月海南省3所三级甲等医院确诊的19例多杀巴斯德菌感染病例的临床资料及菌株,采用 MALDI-TOF MS质谱仪(VITEK MS)和kmt基因聚合酶链式反应(PCR)进行菌种鉴定,通过16S rRNA基因全长测序构建系统发育树.采用多重PCR检测荚膜血清型(A/B/D/E/F)和LPS基因型(L1~L8),基于RIRDC-MLST分型系统进行序列型分析.采用纸片扩散法检测8种抗菌药物的抑菌圈直径,采用头孢硝噻吩法检测β-内酰胺酶活性.结果 19株临床分离株经鉴定均为多杀巴斯德菌,16S rRNA基因序列分析显示菌株间存在单核苷酸多态性差异.基于RIRDC-MLST,13株(68.42%)鉴定为7种已知序列型(ST5、ST7、ST9、ST50、ST129、ST287、ST487),6株(31.58%)未匹配现有数据库.荚膜血清型分布显示A型占优势(13/19,68.42%),LPS基因型中L3型占比最高(8/19,42.11%).药敏试验显示复方磺胺甲口恶唑敏感率最高(19株,100%),青霉素、氨苄西林与四环素敏感率均为78.95%(15株),头孢曲松敏感率为89.47%(17株),红霉素耐药率为100%(19株),阿奇霉素与左氧氟沙星敏感率均为94.74%(18株).β-内酰胺酶阳性率为21.05%(4株).结论 本研究中19株多杀巴斯德菌临床分离株呈现显著的分子多样性,序列型ST7与荚膜A型可能为本地区优势型别,建议临床避免经验性使用青霉素与氨苄西林,需根据药敏试验结果选用敏感抗菌药物.

Objective To analyze the clinical characteristics,antimicrobial susceptibility profiles,and molecular typing features of clinically isolated Pasteurella multocida(P.multocida),and provide basis for clinical diagnosis and treatment.Methods Clinical data and strains of 19 confirmed cases with P.multocida infection in three tertia-ry first-class hospitals in Hainan Province from December 2020 to December 2024 were retrospectively collected.The strains were identified by matrix-assisted laser desorption ionization time-of-flight mass spectrometry(MALDI-TOF MS)and kmt gene polymerase chain reaction(PCR),and a phylogenetic tree was constructed by full-length 16S rRNA gene sequencing.Capsule serotypes(A/B/D/E/F)and LPS genotypes(L1-L8)were detected by multi-plex PCR.Sequence typing analysis was performed based on the RIRDC-MLST typing system.The diameters of the inhibition zone of 8 antimicrobial agents were detected using Kirby-Bauer disc diffusion method,and the activity of β-lactamase activity was detected by nitrocefin test.Results 19 clinical strains were all identified as P.multoci-da,and 16S rRNA gene sequence analysis showed single nucleotide polymorphism differences among the strains.Based on RIRDC-MLST,13 strains(68.42%)were identified as 7 known sequence types(ST5,ST7,ST9,ST50,ST129,ST287,ST487),and 6 strains(31.58%)didn't match the existing database.The distribution of capsule serotypes showed that type A was dominant(13/19,68.42%),and the L3 genotype had the highest proportion among LPS genotypes(8/19,42.11%).Antimicrobial susceptibility testing results showed the highest susceptibility rate of 100%(n=19)for compound sulfamethoxazole and the susceptibility rate of 78.95%(n=15)for penicillin,ampicillin,and tetracycline.Ceftriaxone had a susceptibility rate of 89.47%(n=17).The resistance rate of eryth-romycin was 100%(n=19),and the susceptibility rate of azithromycin and levofloxacin were both 94.74%(n=18).The positive rate of β-lactamase was 21.05%(n=4).Conclusion The 19 clinical strains of P.multocida in this study showed a significant molecular diversity,and the sequence type ST7 and capsule type A may be the domi-nant types in this region.It is recommended to avoid empirical use of penicillin and ampicillin in clinical practice,and select susceptible antimicrobial agents based on antimicrobial susceptibility testing results.

陈映;王会玉;李洪;王琼瑛;黄广定;王宇萌

琼海市人民医院检验科,海南 琼海 571400琼海市人民医院检验科,海南 琼海 571400琼海市人民医院检验科,海南 琼海 571400琼海市人民医院检验科,海南 琼海 571400琼海市人民医院检验科,海南 琼海 571400中国疾病预防控制中心传染病预防控制所,北京 102206

医药卫生

多杀巴斯德菌临床特征分子分型耐药性流行病学

Pasteurella multocidaclinical characteristicsmolecular typingantimicrobial resistanceepide-miology

《中国感染控制杂志》 2026 (1)

25-31,7

国家重点研发计划项目(2024YFC2310100)

10.12138/j.issn.1671-9638.20262636

评论